Non-invasive Biomarkers for irAE and IMTX Response: Computational Science in Immuno-oncology
Join Drs. Alexandra-Chloé Villani (presenter) and Carsten Krieg (moderator) as they identify the current state of the science and address participant questions for what the future holds.
This webinar is part of the 2025 SITC-NCI Computational Immuno-oncology Webinar Series, which is focusing methods and clinical utility for biomarker development in immune-oncology. This is the fourth of ten free webinar set to help individual research labs overcome the computational challenges of analyzing and integrating different assay data throughout the spectrum of immuno-oncology for biomarker development. The annual series aims to educate early-career scientists, increase participants’ awareness of and engagement in NCI-supported Immunotherapy Networks, and fulfill the goal of accelerating progress in cancer research.
Dr. Villiani the director of the Single-Cell Genomics Program at the Center for Immunology and Inflammatory Diseases. She’s also an assistant professor of medicine at Harvard Medical School, and an associate scientist at the Broad Institute of MIT and Harvard.
Dr. Krieg is an assistant professor in the department of pathology and laboratory medicine at the Medical University of South Carolina.
Upcoming Events
- Lesion Tracker and OHIF Web Image ViewerJune 17, 2025NCI Emerging Technologies Seminar: Programs and Resources to Support Technology Development for Cancer ResearchJune 17, 2025Non-invasive Biomarkers for irAE and IMTX Response: Computational Science in Immuno-oncologyJune 18, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025